Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$226.56K

Mahon Paul A EVP & General Counsel

Transaction date Oct 1, 2026
Public filing date Oct 1, 2026
Filing lag Filed same day

UTHR daily price context

Close on/before transaction
$571.38 Oct 1, 2026
First close after public filing
$541.7 Oct 2, 2026
30-day return after filing
+10.05% Through Nov 2, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
400 shares @ $566.41
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001231589-26-000021
Filing cohort

Transactions in this filing

Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$5.9M
Buys / sales
0 / 10
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Sale Oct 1, 2026 $470.96K
United Therapeutics Corp UTHR Sale Oct 1, 2026 $829.08K
United Therapeutics Corp UTHR Sale Oct 1, 2026 $408.79K
United Therapeutics Corp UTHR Sale Oct 1, 2026 $91.7K
United Therapeutics Corp UTHR Exercise Oct 1, 2026 $0
United Therapeutics Corp UTHR Current Sale Oct 1, 2026 $226.56K
United Therapeutics Corp UTHR Sale Oct 1, 2026 $420.6K
United Therapeutics Corp UTHR Exercise Oct 1, 2026 $1.21M
United Therapeutics Corp UTHR Sale Oct 1, 2026 $491.31K
United Therapeutics Corp UTHR Sale Oct 1, 2026 $438.26K
United Therapeutics Corp UTHR Sale Oct 1, 2026 $833.37K
United Therapeutics Corp UTHR Sale Oct 1, 2026 $478.41K